For: | Dahlan Y, Ather HM, Al-ahmadi M, Batwa F, Al-hamoudi W. Sustained virological response in a predominantly hepatitis C virus genotype 4 infected population. World J Gastroenterol 2009; 15(35): 4429-4433 [PMID: 19764095 DOI: 10.3748/wjg.15.4429] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4429.htm |
Number | Citing Articles |
1 |
|
2 |
Mahmoud A. Khattab, Peter Ferenci, Stephanos J. Hadziyannis, Massimo Colombo, Michael P. Manns, Piero L. Almasio, Rafael Esteban, Ayman A. Abdo, Stephen A. Harrison, Nazir Ibrahim, Patrice Cacoub, Mohammed Eslam, Samuel S. Lee. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. Journal of Hepatology 2011; 54(6): 1250 doi: 10.1016/j.jhep.2010.11.016
|
3 |
Hisham O Akbar, Ahmad Al Ghamdi, Faten Qattan, Hind I Fallatah, Maha Al Rumani. Chronic Hepatitis C in Saudi Arabia: Three Years Local Experience in a University Hospital. Hepatitis Monthly 2012; 12(9) doi: 10.5812/hepatmon.6178
|
4 |
AbdullahS Alghamdi, FaisalM Sanai, Mona Ismail, Hamdan Alghamdi, Khalid Alswat, Adel Alqutub, Ibrahim Altraif, Hemant Shah, FalehZ Alfaleh. SASLT practice guidelines: Management of hepatitis C virus infection. Saudi Journal of Gastroenterology 2012; 18(7): 1 doi: 10.4103/1319-3767.101155
|
5 |
Gouda K. Helal, Magdy A. Gad, Mohamed F. Abd-Ellah, Elsayed M. Mahgoup. Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients. European Journal of Gastroenterology & Hepatology 2016; 28(5): 553 doi: 10.1097/MEG.0000000000000587
|
6 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
7 |
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Heidar Sharafi, Farzin Sadeghi, Seyed Moayed Alavian. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.40357
|
8 |
Suhair M. Abozaid, Mohamed Shoukri, Ahmad Al-Qahtani, Mohammed N. Al-Ahdal. Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence. Annals of Saudi Medicine 2013; 33(1): 1 doi: 10.5144/0256-4947.2013.1
|
9 |
|
10 |
S. K. Tohra, S. Taneja, S. Ghosh, B. K. Sharma, A. Duseja, R. K. Dhiman, A. Das, Y. K. Chawla. Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C. Digestive Diseases and Sciences 2011; 56(8): 2449 doi: 10.1007/s10620-011-1770-3
|
11 |
Eric M. Yoshida, Nahum Méndez-Sánchez. Hepatology Highlights. Annals of Hepatology 2010; 9(2): 117 doi: 10.1016/S1665-2681(19)31649-7
|